Anton Peleg is a Professor of Infectious Diseases and Microbiology, Director of the Department of Infectious Diseases at The Alfred Hospital and Monash University, Director of the Centre to Impact Antimicrobial Resistance (AMR), Monash University, and Theme Leader for Infection and Immunity at the Monash Academic Health Research and Translational Centre. He has also recently been elected as a Fellow of the Australian Academy of Health and Medical Sciences.

 He completed his infectious diseases clinical training in Australia in 2005 and then went to the USA for four years and trained at the Harvard-affiliated hospitals; Beth Israel Deaconess Medical Center and Massachusetts General Hospital. He completed a Masters of Public Health at Harvard School of Public Health, and also completed a PhD in Infectious Diseases and Microbiology with a focus on AMR and microbial genomics. He returned to Australia in 2010 as a clinician-scientist and has built a large research program that spans fundamental, translational and clinical research.

 His research interests are in hospital-acquired infections, AMR and novel solutions, bacteriophage therapy, bacterial genomics, applications of AI to healthcare, mechanisms of pathogenesis and infections in immunocompromised hosts. He is the lead investigator on numerous AMR-related projects that focus on hospital, community, aged care, and regional settings. He is also an active clinician working in the area of transplant infectious diseases and hospital-acquired infections. He has received numerous national and international awards for his advanced research and contribution to Infectious Diseases and Microbiology.